OTC Markets OTCPK - Delayed Quote • USD Medivolve Inc. (MEDVF) Follow Compare 0.0070 +0.0005 +(7.69%) At close: January 17 at 3:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Medivolve Announces Management Changes TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (OTC: MEDVF; FRA: 4NC) announces today that David Preiner has resigned from his position as president and chief executive officer of the Company, effective August 26, 2024. Mr. Preiner will continue to support the Company in his capacity as a consultant. The board and management thanks Preiner for his service and contributions and wish him well in his future endeavours. About Medivolve Medivolve is a Canadia Medivolve Announces Change of Auditor TORONTO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve” or the “Company”) (Cboe CA: MEDV; OTC: MEDVF; FRA:4NC) announces that it has changed auditors from MNP LLP (“MNP”) to MS Partners LLP (“MS Partners”), effective February 6, 2024. MNP resigned as of the effective date of January 16, 2024, and MS Partners has been appointed as the successor auditor. In accordance with National Instrument 51‐102 (“NI 51‐102”), the Company has filed a Change of Auditor Notice on SEDAR+ together w Performance Overview Trailing total returns as of 1/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return MEDVF S&P 500 YTD +40.00% +2.41% 1-Year -53.33% +24.99% 3-Year -88.89% +34.95%